Interview: Biocon's Chairman MD: Kiran Mazumdar-Shaw
  • 6 years ago
Kiran Mazumdar-Shaw talks about Biocon's strategy after Pfizer?s exit and why she thinks the regulatory environment is holding back biotech growth.